MYCN and neuroblastoma: In 1986, it was also shown that retinoblastoma tumor formation was not necessarily dependent on the oncogene MYCN, which was commonly amplified and highly expressed in retinoblastomas (as in neuroblastoma) that had lost RB1, likely contributing to tumor progression but not initiation [22].